AAP News Vol. 4 No. 9 September 1988, p. 2
© 1988 American Academy of Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

 Previous Article  |  Next Article 

FDA requires new, permanent Reye syndrome warning labels

The federal Food and Drug Administration (FDA) is requiring that all non-prescription aspirin products carry modified, permanent warning labels about Reye syndrome, said FDA spokes-woman Faye Peterson.

The modified warning label states: "Warning: Children and teenagers should not use this medicine for chickn pox or flu symptoms before a doctor is consulted about Reye syndrome, a rare but serious illness reported to be associated with aspirin." The phrase "reported to be associated with aspirin" is new.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?